Effectiveness of Virtual Reality Vision Therapy - VERVE — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Effectiveness of Virtual Reality Vision Therapy - VERVE — Stella

Recruiting

Back to Convergence Insufficiency trials

Early Phase 1 — Very small initial tests in humans, typically just a few people, to make sure the treatment is safe enough to study further.

Trial locations(2 sites)

United States

OculoMotor Technologies, Newark, New Jersey

The Eye Institute at Salus University, Philadelphia, Pennsylvania

Key details

Phase

Very early testing

Sponsor

OculoMotor Technologies

Collaborators

New Jersey Institute of Technology, Salus University

Enrollment target

~50 participants

Started

October 2021

Primary completion

August 2024

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

9 Years – 35 Years

Last updated April 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov